Comparative mutagenicity testing of bropirimine, 1. Induction of chromosome aberrations in CHO cells is not reflected in induction of mutation at the TK locus of L5178Y cells-Reference-Cited by-同舟云学术

Comparative mutagenicity testing of bropirimine, 1. Induction of chromosome aberrations in CHO cells is not reflected in induction of mutation at the TK locus of L5178Y cells

Published:1991-06 Issue:3 Volume:252 Page:221-228
ISSN:0165-1161
Container-title:Mutation Research/Environmental Mutagenesis and Related Subjects
language:en
Short-container-title:Mutation Research/Environmental Mutagenesis and Related Subjects

Author:

Aaron C.S.,Petry T.W.,Thilagar A.,Kumaroo P.V.,Kirby P.

Publisher

Elsevier BV

Subject

Genetics,Toxicology

Reference16 articles.

1. Evaluation of drug candidates in a battery of short-term genetic toxicology assays: Overview;Aaron;Mutation Res.,1989

2. The Salmonella mutagenicity test: Evaluation of 29 drug candidates;Aaron;Mutation Res.,1989

3. The in vitro unscheduled DNA synthesis assay in rat primary hepatocytes: Evaluation of 24 drug candidates;Aaron;Mutation Res.,1989

4. Comparative mutagenicity testing of bropirimine, 3. Bropirimine does not induce cytogenetic damage in vivo in the rat but does produce micronuclei in the mouse;Aaron;Mutation Res.,1991

5. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells;Clive;Mutation Res.,1975

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Amino-5-Bromo-6-Phenyl-4(1H)-Pyrimidinone 56741-95-8;Sax's Dangerous Properties of Industrial Materials;2004-10-15

2. The L5178Y/tk+/− mouse lymphoma specific gene and chromosomal mutation assay;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;1997-11

3. Comparison of common gene mutation tests in mammalian cells in culture: a position paper of the GUM Commission for the Development of Guidelines for Genotoxicity Testing;Mutation Research/Environmental Mutagenesis and Related Subjects;1994-08

4. Risk and Benefit Evaluation in Development of Pharmaceutical Products;Environmental Health Perspectives;1993-10

5. Risk and benefit evaluation in development of pharmaceutical products.;Environmental Health Perspectives;1993-10